NFKB1 and neoplasm: TLRs may promote tumor progression by acting directly on cancer cells, resulting in increased tumor cell-endothelial cell adhesion, tumour cell-extracellular matrix adhesion, and tumor cell-extracellular matrix invasion through NF-κB-mediated upregulation of β-1 integrin.